Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
26.53 BRL | +21.14% | -1.12% | +21.36% |
Mar. 20 | Braskem Q4 Net Loss Shrinks, Revenue Drops -- Shares Surge | MT |
Mar. 19 | Transcript : Braskem S.A., Q4 2023 Earnings Call, Mar 19, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.76 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
Weaknesses
- The company has insufficient levels of profitability.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.36% | 4.32B | C+ | ||
+9.48% | 109B | A- | ||
-6.47% | 61.6B | A- | ||
+4.73% | 34.64B | B | ||
+8.03% | 33.41B | A- | ||
+10.95% | 31.17B | B | ||
+9.13% | 19.53B | B- | ||
+9.93% | 18.93B | B+ | ||
+6.09% | 15.7B | C+ | ||
+4.83% | 14.64B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Braskem S.A. - Sao Paulo
- Ratings Braskem S.A.